Iconovo AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ICO.ST research report →
Companywww.iconovo.se
Iconovo AB (publ) develops and licenses inhalation devices in Sweden. It develops ICOres, a flexible multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler, as well as provides customized inhalation solutions. It serves generic companies.
- CEO
- Anders Mansson
- IPO
- 2018
- Employees
- 26
- HQ
- Lund, SE
Price Chart
Valuation
- Market Cap
- $58.76M
- P/E
- -2.17
- P/S
- 44.75
- P/B
- 0.55
- EV/EBITDA
- -0.66
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -2018.28%
- Op Margin
- -3062.38%
- Net Margin
- -3068.70%
- ROE
- -29.53%
- ROIC
- -24.60%
Growth & Income
- Revenue
- $1.10M · -62.34%
- Net Income
- $-43,364,000 · -5.41%
- EPS
- $-1.14 · 55.64%
- Op Income
- $-43,753,000
- FCF YoY
- 100.00%
Performance & Tape
- 52W High
- $2.79
- 52W Low
- $0.91
- 50D MA
- $1.17
- 200D MA
- $1.49
- Beta
- 0.38
- Avg Volume
- 75.56K
Get TickerSpark's AI analysis on ICO.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our ICO.ST Coverage
We haven't published any research on ICO.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ICO.ST Report →